These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 17316926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Horizontal transmission dynamics of a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus and the effect of vaccination on transmission of virulent virus.
    Devlin JM, Hartley CA, Gilkerson JR, Coppo MJ, Vaz P, Noormohammadi AH, Wells B, Rubite A, Dhand NK, Browning GF.
    Vaccine; 2011 Aug 05; 29(34):5699-704. PubMed ID: 21689710
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the protection elicited by direct and indirect exposure to live attenuated infectious laryngotracheitis virus vaccines against a recent challenge strain from the United States.
    Rodríguez-Avila A, Oldoni I, Riblet S, Garcia M.
    Avian Pathol; 2008 Jun 05; 37(3):287-92. PubMed ID: 18568655
    [Abstract] [Full Text] [Related]

  • 8. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
    Mashchenko A, Riblet SM, Zavala G, García M.
    Avian Dis; 2013 Jun 05; 57(2 Suppl):523-31. PubMed ID: 23901771
    [Abstract] [Full Text] [Related]

  • 9. Development of an enzyme-linked immunosorbent assay to detect chicken serum antibody to glycoprotein G of infectious laryngotracheitis virus.
    Shil NK, Markham PF, Noormohammadi AH, O'Rourke D, Devlin JM.
    Avian Dis; 2012 Sep 05; 56(3):509-15. PubMed ID: 23050467
    [Abstract] [Full Text] [Related]

  • 10. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.
    Vaccine; 2009 Jan 29; 27(5):773-85. PubMed ID: 19041677
    [Abstract] [Full Text] [Related]

  • 11. Attenuation and protection efficacy of ORF C gene-deleted recombinant of infectious laryngotracheitis virus.
    Garcia M, Spatz SJ, Cheng Y, Riblet SM, Volkening JD, Schneiders GH.
    J Gen Virol; 2016 Sep 29; 97(9):2352-2362. PubMed ID: 27283114
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M, Kumar S, Khattar SK, Gebreluul GT, Paldurai A, Samal SK.
    Vaccine; 2014 Jun 12; 32(28):3555-63. PubMed ID: 24793943
    [Abstract] [Full Text] [Related]

  • 14. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA, Hartley CA, Coppo MJC, Browning GF, Beltrán G, Riblet S, Freitas CO, García M, Devlin JM.
    Appl Environ Microbiol; 2018 Dec 01; 84(23):. PubMed ID: 30242009
    [Abstract] [Full Text] [Related]

  • 15. Replication-independent reduction in the number and diversity of recombinant progeny viruses in chickens vaccinated with an attenuated infectious laryngotracheitis vaccine.
    Loncoman CA, Hartley CA, Coppo MJC, Browning GF, Quinteros JA, Diaz-Méndez A, Thilakarathne D, Fakhri O, Vaz PK, Devlin JM.
    Vaccine; 2018 Sep 11; 36(38):5709-5716. PubMed ID: 30104116
    [Abstract] [Full Text] [Related]

  • 16. Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
    Thilakarathne DS, Coppo MJC, Hartley CA, Diaz-Méndez A, Quinteros JA, Fakhri O, Vaz PK, Devlin JM.
    PLoS One; 2019 Sep 11; 14(3):e0213866. PubMed ID: 30921344
    [Abstract] [Full Text] [Related]

  • 17. Relationship between mortality, clinical signs and tracheal pathology in infectious laryngotracheitis.
    Kirkpatrick NC, Mahmoudian A, Colson CA, Devlin JM, Noormohammadi AH.
    Avian Pathol; 2006 Dec 11; 35(6):449-53. PubMed ID: 17121733
    [Abstract] [Full Text] [Related]

  • 18. Immune responses to infectious laryngotracheitis virus.
    Coppo MJ, Hartley CA, Devlin JM.
    Dev Comp Immunol; 2013 Nov 11; 41(3):454-62. PubMed ID: 23567343
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.
    Coppo MJ, Devlin JM, Noormohammadi AH.
    Avian Pathol; 2012 Nov 11; 41(1):99-106. PubMed ID: 22845327
    [Abstract] [Full Text] [Related]

  • 20. Cross-protective immune responses between genotypically distinct lineages of infectious laryngotracheitis viruses.
    Lee SW, Markham PF, Coppo MJ, Legione AR, Shil NK, Quinteros JA, Noormohammadi AH, Browning GF, Hartley CA, Devlin JM.
    Avian Dis; 2014 Mar 11; 58(1):147-52. PubMed ID: 24758128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.